The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalculus Vct Regulatory News (CLC)

Share Price Information for Calculus Vct (CLC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 60.00
Bid: 50.00
Ask: 70.00
Change: 0.00 (0.00%)
Spread: 20.00 (40.00%)
Open: 60.00
High: 60.00
Low: 50.00
Prev. Close: 60.00
CLC Live PriceLast checked at -
Calculus VCT is an Investment Trust

To invest primarily in a diverse portfolio of VCT qualifying UK growth companies whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

4 Feb 2019 10:02

RNS Number : 9740O
Calculus VCT PLC
04 February 2019
 

4 February 2019

Calculus VCT Plc

 

Changes to the Board

 

Calculus VCT announces a number of Board changes.

 

Michael O'Higgins has informed the Board of his intention to step down as Chairman at the conclusion of the Company's AGM to devote his time to his other business and charitable commitments. Michael has been Chairman since 10 February 2011 and the Board thanks him for his leadership and wise counsel throughout the period of his chairmanship. The Company's AGM is currently planned to take place on 4 July 2019.

 

The Board announces the appointment of Jan Ward CBE as a non-executive director of the company with effect from 1 March 2019. Jan will become Chairman on the retirement from the Board of Michael O'Higgins. Jan brings strategic and operational experience gained from more than thirty years in the oil, gas, petrochem and power industries. Jan is the founder and CEO of Corrotherm International Ltd which specialises in supplying advanced metals for fabricating oil, gas and power generating equipment. Corrotherm is a significant exporter of UK manufactured products and has grown to 10 offices globally. Jan was named a CBE in the 2015 New Year's Honours list for services to business. In 2009, Jan was named the UK's most inspirational female entrepreneur, winning the NatWest Everywoman Award which champions female entrepreneurs. Her range of experience and understanding of growth companies will be a valuable contribution to the Company.

 

Under Listing Rule 9.6.13R (1), Jan has had the following directorships in the last five years:

Hardide plc (resigned 2018)

 

The Company hereby confirms that there are no further disclosures to make in accordance Rule 9.6.13 (1) to (6) of the Listing Rules of the UK Listing Authority.

 

Diane Seymour Williams, who was Chairman of the Neptune-Calculus Income and Growth VCT plc and who joined the Board of the Calculus VCT at the time of the merger of the two VCTs, has informed the Board of her intention to step down from the Board to devote her time to her other quoted directorships. Diane will leave the Board on 28 February 2019. The Board thanks her for her guidance and her assistance and support in ensuring a smooth merger of the two VCTs.

 

Following Michael O'Higgins' retirement at the conclusion of the Company's AGM, the non-executive directors will be Jan Ward CBE (Chair), Kate Cornish Bowden (Chair of the Audit Committee) and Claire Olsen.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOATIMMTMBMMBML
Date   Source Headline
15th Jun 20219:18 amRNSCorrection to the AGM notice
21st May 20214:02 pmRNSCorrection to Dividend Record Date
21st May 20217:00 amRNSAnnual Financial Report
1st Apr 20214:06 pmRNSTotal Voting Rights
9th Mar 20213:24 pmRNSNet Asset Value 31 January 2021
23rd Feb 202110:14 amRNSTransaction in Own Shares
16th Dec 20205:35 pmRNSIssue of Equity and Total Voting Rights
15th Dec 202011:33 amRNSNet Asset Value(s)
23rd Oct 20201:31 pmRNSHalf-year Report
11th Sep 202012:03 pmRNSIssue of Equity - Amendment
8th Sep 20201:01 pmRNSPublication of a Prospectus
8th Sep 202012:51 pmRNSPublication of a Prospectus
3rd Sep 20202:46 pmRNSIssue of Equity
31st Jul 202012:46 pmRNSDirector/ PDMR shareholding
3rd Jul 20204:42 pmRNSResult of AGM
3rd Jul 20204:09 pmRNSDirectorate Change
18th Jun 20204:45 pmRNSTransaction in Own Shares
17th Jun 20205:34 pmRNSNet Asset Value 31 May 2020
17th Jun 20205:07 pmRNSNet Asset Value 31 May 2020
27th May 20203:40 pmRNSAnnual Financial Report
21st May 20204:09 pmRNSDirector Declaration
3rd Apr 20204:15 pmRNSIssue of Equity
31st Mar 20202:18 pmRNSNet Asset Value(s) and Impact of Covid-19
19th Dec 20194:22 pmRNSNet Asset Value(s)
12th Dec 201911:29 amRNSIssue of Equity and Correction
18th Oct 20194:40 pmRNSHalf-year Report
24th Sep 20192:18 pmRNSPublication of a Prospectus
6th Sep 201911:22 amRNSIssue of Equity
4th Sep 20193:20 pmRNSNet Asset Value(s)
31st Jul 20192:48 pmRNSTransaction in Own Shares
4th Jul 20194:24 pmRNSResult of AGM
26th Jun 20192:25 pmRNSIssue of Equity
14th Jun 20199:52 amRNSNet Asset Value(s)
9th May 20195:49 pmRNSAnnual Financial Report - Replacement
9th May 20194:12 pmRNSAnnual Financial Report
5th Apr 20193:49 pmRNSIssue of Equity
28th Feb 201910:41 amRNSIssue of Equity
22nd Feb 20194:46 pmRNSNet Asset Value(s)
4th Feb 201910:02 amRNSDirectorate Change
24th Jan 201910:19 amRNSHolding(s) in Company
23rd Jan 201912:46 pmRNSIssue of Equity
16th Jan 20192:45 pmRNSNet Asset Value(s)
8th Jan 20193:49 pmRNSNet Asset Value(s)
18th Dec 201812:42 pmRNSDirector Declaration
13th Dec 20183:34 pmRNSDirectorate Change
6th Nov 201810:17 amRNSTransaction in Own Shares
23rd Oct 20184:32 pmRNSHalf-year Report
9th Oct 20183:21 pmRNSGM Statement
17th Sep 20184:33 pmRNSHolding(s) in Company
17th Sep 20184:33 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.